Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
Completed
Presbyopia Therapies, LLC
Phase 2
This is a one-day, randomized, double-masked, single-center evaluation of the efficacy and
safety of PRX-100 ophthalmic solution compared to placebo in 20 subjects (randomized 4:1,
PRX-100:placebo) to evaluate the safety of PRX-100 and the magnitude and duration of effects
on improving near-vision acuity.
Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia
Recruiting
ORA, Inc.
Phase 2
To evaluate the safety and effectiveness of Aceclidine/Brimonidine (LNZ101) compared with
Aceclidine (LNZ100) and vehicle in the treatment of Presbyopia.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
